Get the Stockscreener App
18.01
0.90%
0.16
After Hours:
18.02
0.010
+0.06%
Stevanato Group Spa stock is traded at $18.01, with a volume of 218.68K.
It is up +0.90% in the last 24 hours and up +15.75% over the past month.
Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables and its other segment is Engineering. Geographically, It derives its majority revenue from Europe, Middle East and Africa.
See More
Previous Close:
$17.85
Open:
$17.84
24h Volume:
218.68K
Relative Volume:
0.39
Market Cap:
$4.92B
Revenue:
$1.40B
Net Income/Loss:
$164.00M
P/E Ratio:
29.97
EPS:
0.6009
Net Cash Flow:
$-11.09M
1W Performance:
+0.11%
1M Performance:
+15.75%
6M Performance:
-19.53%
1Y Performance:
-20.34%
1-Day Range:
$17.84
$18.44
1-Week Range:
$17.23
$18.44
52-Week Range:
$12.89
$28.00
Stevanato Group Spa Stock (STVN) Company Profile
Name
Stevanato Group Spa
Sector
Industry
Phone
-
Address
-
Compare STVN vs ISRG, BDX, ALC, MDLN, RMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
STVN
Stevanato Group Spa
|
18.01 | 4.87B | 1.40B | 164.00M | -11.09M | 0.6009 |
ISRG
Intuitive Surgical Inc
|
438.10 | 155.76B | 10.58B | 3.00B | 2.83B | 8.2437 |
BDX
Becton Dickinson Co
|
147.63 | 40.30B | 21.37B | 1.41B | 3.07B | 3.9437 |
ALC
Alcon Inc
|
67.78 | 33.13B | 10.63B | 819.00M | 1.59B | 1.6577 |
MDLN
Medline Inc
|
37.01 | 31.37B | 29.14B | 1.07B | 1.05B | 1.1956 |
RMD
Resmed Inc
|
208.05 | 30.31B | 5.54B | 1.52B | 1.74B | 10.37 |
Stevanato Group Spa Stock (STVN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-02-25 | Resumed | Morgan Stanley | Equal-Weight |
| Dec-13-24 | Initiated | Wolfe Research | Outperform |
| Dec-03-24 | Resumed | Morgan Stanley | Equal-Weight |
| Apr-22-24 | Initiated | Exane BNP Paribas | Outperform |
| Nov-01-23 | Downgrade | Jefferies | Buy → Hold |
| Sep-26-23 | Initiated | Stephens | Overweight |
| Sep-19-23 | Initiated | CJS Securities | Market Outperform |
| Aug-24-23 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Aug-10-21 | Initiated | BofA Securities | Buy |
| Aug-10-21 | Initiated | Citigroup | Buy |
| Aug-10-21 | Initiated | Jefferies | Buy |
| Aug-10-21 | Initiated | KeyBanc Capital Markets | Overweight |
| Aug-10-21 | Initiated | Morgan Stanley | Overweight |
| Aug-10-21 | Initiated | Wells Fargo | Overweight |
View All
Stevanato Group Spa Stock (STVN) Latest News
Stevanato Group S.p.A. (STVN) Stock Analysis: Unpacking a Potential 37.89% Upside in the Healthcare Sector - DirectorsTalk Interviews
Stevanato maintains 2026 guidance of €1.260B-€1.290B revenue as it targets RTU cartridge production in early 2027 - MSN
Stevanato Group Earnings Call Highlights Growth and Strain - TipRanks
Stevanato Group Posts Strong Q1 2026 Growth and Accelerates Cartridge Capacity Expansion - TipRanks
Stevanato Group S.p.A. (STVN) Stock Analysis: A 38% Potential Upside Draws Investor Attention - DirectorsTalk Interviews
Liquidity Mapping Around (STVN) Price Events - Stock Traders Daily
Stevanato Group S.p.A. Ordinary Shares (NY: STVN - The Chronicle-Journal
Stevanato Group (NYSE: STVN) posts Q1 2026 growth and reaffirms 2026 outlook - Stock Titan
Baron entities (STVN) report 2.5M shares, 5.03% beneficial ownership - Stock Titan
T. Rowe Price holds 6.5% of Stevanato Group (STVN) in amended 13G/A - Stock Titan
Earnings call transcript: Stevanato Group Q1 2026 meets EPS, stock dips - Investing.com Nigeria
Earnings call transcript: Stevanato Group Q1 2026 meets EPS, stock dips By Investing.com - Investing.com South Africa
Transcript : Stevanato Group S.p.A. Presents at Bank of America Global Healthcare Conference 2026, May-12-2026 08 - marketscreener.com
Stevanato Group Calls May 26, 2026 Teleconference Shareholders’ Meeting to Approve 2025 Results and Board Slate - The Globe and Mail
STVN SEC FilingsStevanato Group S P A 10-K, 10-Q, 8-K Forms - Stock Titan
Stevanato Group releases reports and shareholder meeting notice in SEC filing - Investing.com Australia
Stevanato Group releases reports and shareholder meeting notice in SEC filing By Investing.com - Investing.com South Africa
Ampoules Packaging Market (2026) | Glass & Plastic Packaging & - openPR.com
Stevanato Group S.p.A. (STVN) Stock Analysis: Healthcare Innovator with 36% Potential Upside - DirectorsTalk Interviews
Number of shareholders of Stevanato Group SpA – FWB:87N - TradingView
Stevanato Group (NYSE:STVN) Margin Uptick Tests Bullish Earnings Narrative After Q1 2026 Results - Sahm
Earnings Beat: Stevanato Group S.p.A. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models - Yahoo Finance
Stevanato Group S.p.A. (NYSE:STVN) Q1 2026 Earnings Call Transcript - Insider Monkey
Stevanato Group S.p.A. Just Recorded A 12% EPS Beat: Here's What Analysts Are Forecasting Next - Moomoo
Stevanato Group Earnings Call: Growth With Constraints - TipRanks
Stevanato Group (NYSE:STVN) Issues Earnings Results, Misses Estimates By $0.01 EPS - MarketBeat
Stevanato (STVN) Q1 2026 Earnings Transcript - The Globe and Mail
Stevanato Group S.p.A. Q1 2026 Earnings Call Summary - Yahoo Finance
Stevanato Group Q1 2026 presentation: GLP-1s fuel 10% revenue gain - Investing.com Australia
Stevanato Group Q1 2026 presentation: GLP-1s fuel 10% revenue gain By Investing.com - Investing.com South Africa
Stevanato Group Delivers 7% Revenue Growth (10% at Constant Currency) for the First Quarter of Fiscal 2026 - The National Law Review
Stevanato Group Files Form 6-K Detailing Q1 2026 Results Presentation - TipRanks
Stevanato Group Files First-Quarter 2026 Interim Report Highlighting Risk Landscape - TipRanks
Stevanato Group Posts Q1 2026 Revenue Growth and Reaffirms Full-Year Guidance - TipRanks
Stevanato Group (STVN) posts higher Q1 2026 profit and strong cash flow - Stock Titan
Stevanato Group (NYSE: STVN) posts Q1 2026 growth and keeps 2026 outlook - Stock Titan
Stevanato Group (NYSE: STVN) posts 7% Q1 growth, keeps 2026 outlook - Stock Titan
Earnings call transcript: Stevanato Group Q1 2026 revenue beats forecast, stock dips - Investing.com Canada
Earnings call transcript: Stevanato Group Q1 2026 revenue beats forecast, stock dips By Investing.com - Investing.com South Africa
Stevanato Group S.p.A. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
Stevanato Group Q1 2026 Earnings Call Transcript - MarketBeat
Stevanato Group SpA reports results for the quarter ended December 31Earnings Summary - TradingView
Stevanato Group Q1 Adjusted Earnings Fall, Revenue Rise; 2026 Guidance Maintained - marketscreener.com
Stevanato Group (STVN) Q1 Earnings and Revenues Beat Estimates - Yahoo Finance
Stevanato Group (NYSE:STVN) Releases FY 2026 Earnings Guidance - MarketBeat
Earnings Flash (STVN) Stevanato Posts Q1 Operating Revenue 273.6M Euros, vs. FactSet Est of 268.7M Euros - marketscreener.com
Earnings Flash (STVN) Stevanato Posts Q1 Adjusted EPS 0.11 Euros, vs. FactSet Est of 0.10 Euros - marketscreener.com
Stevanato: Q1 Earnings Snapshot - marketscreener.com
Stevanato Group Spa Stock (STVN) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.79%
0.48%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):